Clinical Trial Update: A Study of Vascular Endothelial Growth Factor (VEGF) Inhibition in Patients With Unilateral Upper Extremity Lymphedema Following Treatment for Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing VEGF inhibition for unilateral upper extremity lymphedema after cancer treatment; study completed with posted results in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphedema

Drugs mentioned

• VEGF inhibitor

Snippet

Sponsor: Kathy Miller | Conditions: Lymphedema | Phase 2 | Status: COMPLETED | Results posted: 2014-10-16